KV Acquires Rights to Menopause Transdermal Spray
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 83 (Table of Contents)
Published: 7 May-2007
DOI: 10.3833/pdr.v2007.i83.351 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
KV entered into agreement with VIVUS to acquire US marketing rights to EvaMist™, which is phase 3 clinical trials for treating vasomotor symptoms associated with menopause...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS